Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
<p>Differentially methylated regions with at least five CpGs, and a mean difference of greater than 20% between day 14 and baseline white blood cells</p>
Tallennettuna:
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|